---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-003446"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:57:35.343343+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Valion Bio appoints Melinda Lackey as General Counsel and SVP of Legal Affairs

## Summary
- Melinda Lackey, age 49, appointed as GC and SVP of Legal Affairs, effective May 4, 2026.
- Prior role: SVP Legal & Administration at Alaunos Therapeutics (TCRT); also served at Kuur Therapeutics and Winston & Strawn.
- Employment agreement: base salary $321,000/year, eligible for annual bonus up to 35% of base, and option grant of 45,000 shares.
- Lackey will oversee legal functions for Valion's Entolimod ARS program and CDMO subsidiary Velocity Bioworks.
- Company (Nasdaq: VBIO) is a clinical-stage immunotherapeutics firm advancing Entolimod via FDA Animal Rule pathway.

## SEC filing metadata
- accession: 0001683168-26-003446
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000168316826003446/0001683168-26-003446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000168316826003446/valion_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-003446
- JSON: https://secwatch.observer/filing/0001683168-26-003446.json
- Plain text: https://secwatch.observer/filing/0001683168-26-003446.txt

## Key facts
- Executive change
  Melinda Lackey was appointed as General Counsel and Senior Vice President of Legal Affairs at Valion Bio, Inc..
  - Action: appointed
  - Role: General Counsel and Senior Vice President of Legal Affairs
  source text: On May 4, 2026, Melinda Lackey was appointed as General Counsel and Senior Vice President of Legal Affairs of Valion Bio, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000168316826003446/0001683168-26-003446-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.